BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23297724)

  • 1. Locoregional surgical and interventional therapies for advanced colorectal liver metastasis: expert consensus statement.
    Martin RC; Salem R; Adam R; Dixon E
    HPB (Oxford); 2013 Feb; 15(2):131-3. PubMed ID: 23297724
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection for hepatic resection: expert consensus conference.
    Rees M; Elias D; Coimbra FJ; Orloff SL; ; ;
    HPB (Oxford); 2013 Feb; 15(2):104-5. PubMed ID: 23297720
    [No Abstract]   [Full Text] [Related]  

  • 3. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
    Abdalla EK; Bauer TW; Chun YS; D'Angelica M; Kooby DA; Jarnagin WR
    HPB (Oxford); 2013 Feb; 15(2):119-30. PubMed ID: 23297723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of hepatocellular cancer: expert consensus conference.
    Aloia TA; Hemming A; Schwartz M
    HPB (Oxford); 2010 Jun; 12(5):311-2. PubMed ID: 20590904
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al.
    Adams RB; Haller DG; Roh MS
    Ann Surg Oncol; 2006 Oct; 13(10):1281-3. PubMed ID: 16964448
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving resectability of hepatic colorectal metastases: expert consensus statement.
    Abdalla EK; Adam R; Bilchik AJ; Jaeck D; Vauthey JN; Mahvi D
    Ann Surg Oncol; 2006 Oct; 13(10):1271-80. PubMed ID: 16955381
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus conference.
    Burak KW; Thomas MB; Zhu AX
    HPB (Oxford); 2010 Jun; 12(5):321-2. PubMed ID: 20590906
    [No Abstract]   [Full Text] [Related]  

  • 8. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.
    Charnsangavej C; Clary B; Fong Y; Grothey A; Pawlik TM; Choti MA
    Ann Surg Oncol; 2006 Oct; 13(10):1261-8. PubMed ID: 16947009
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.
    Schwarz RE; Berlin JD; Lenz HJ; Nordlinger B; Rubbia-Brandt L; Choti MA
    HPB (Oxford); 2013 Feb; 15(2):106-15. PubMed ID: 23297721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection for hepatic resection of colorectal liver metastases: expert consensus statement.
    Adams RB; Aloia TA; Loyer E; Pawlik TM; Taouli B; Vauthey JN; ; ;
    HPB (Oxford); 2013 Feb; 15(2):91-103. PubMed ID: 23297719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
    Miura JT; Gamblin TC
    Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej et al.
    Chapman WC; Hoff PM; Strasberg SM
    Ann Surg Oncol; 2006 Oct; 13(10):1269-70. PubMed ID: 16952024
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoembolization of hepatic malignancy.
    Gonsalves CF; Brown DB
    Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.
    Sag AA; Selcukbiricik F; Mandel NM
    World J Gastroenterol; 2016 Mar; 22(11):3127-49. PubMed ID: 27003990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive models in colorectal liver metastases--can we personalize treatment and outcome?
    Welsh FK; Tekkis PP; John TG; Rees M
    Dig Surg; 2008; 25(6):406-12. PubMed ID: 19212112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of liver metastases].
    Loss M; Jung EM; Scherer MN; Farkas SA; Schlitt HJ
    Chirurg; 2010 Jun; 81(6):533-41. PubMed ID: 20428837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic colorectal cancer.
    Bouche O; Conroy T; Michel P; Penna C; Tournigand C
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S30-2S42. PubMed ID: 17151561
    [No Abstract]   [Full Text] [Related]  

  • 18. The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?
    Ersan V; Barut B; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1152-1156. PubMed ID: 32856230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When is first-line resection of hepatic metastasis indicated?].
    Chiche L;
    Gastroenterol Clin Biol; 2003 Mar; 27 Spec No 2():B11-3, B41-61. PubMed ID: 12637872
    [No Abstract]   [Full Text] [Related]  

  • 20. Extending limits of resection for metastatic colorectal cancer: risk benefit ratio.
    Yang AD; Brouquet A; Vauthey JN
    J Surg Oncol; 2010 Dec; 102(8):996-1001. PubMed ID: 21166004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.